ArticleJournal of animal science2025
Endo-1,3-β-D-glucanase activity influences in vitro ruminal fermentation of diets varying in forage:concentrate.
Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With growing concerns to reduce global methane emissions, there is a pressing need to explore alternative strategies to mitigate methane production in ruminant livestock species. The objectives of this study were to evaluate the effects of increasing dosage of endo-1,3-β-D-glucanase on in vitro ruminal fermentation from diets varying in forage:concentrate. Ruminal contents were obtained from 2 ruminally cannulated Angus × Holstein steers. The experimental design was a randomized complete block design with a 3 × 6 factorial arrangement of treatments. The basal substrates (DM basis) were high-forage (90% tall fescue hay, 10% corn; 90F:10C), equal forage:concentrate (50% tall fescue hay, 50% corn; 50F:50C), or high-concentrate (90% corn, 10% tall fescue hay; 10F:90C). Six doses of endo-1,3-β-D-glucanase were tested: 0, 5, 10, 25, 50, and 100 units/100 mL of ruminal inoculum. Recombinant endo-1,3-β-D-glucanase was diluted to working concentrations with 100 mM sodium acetate buffer, and then working solutions (1 mL) were added to fermentation vessels immediately before inoculum addition. Substrates were added to fermentation vessels and incubated for 48 h. There were 2 technical replicates per treatment in each run, and 3 runs to constitute the experiment. Results were analyzed with the GLM procedure of SAS. Increasing dosage of endo-1,3-β-D-glucanase did not influence (P ≥ 0.10) the rate of gas production or cumulative methane production. Cumulative gas production (mL, mL/g substrate, and mL/g substrate digested) increased linearly (P ≤ 0.03) with increasing endo-1,3-β-D-glucanase activity. Microbial biomass, true dry matter (DM) digestibility, apparent DM digestibility, and neutral detergent fiber digestibility were not influenced (P ≥ 0.21) by increasing endo-1,3-β-D-glucanase dose. The molar acetate proportion and acetate:propionate decreased linearly (P < 0.001) with increasing endo-1,3-β-D-glucanase activity. The molar propionate, butyrate, and valerate proportions in the fermentation media linearly increased (P < 0.001) with increasing endo-1,3-β-D-glucanase activity. Decreasing forage:concentrate decreased (P < 0.05) gas and methane production per gram of substrate digested and increased (P < 0.001) digestibility and total short-chain fatty acid (SCFA) concentration. These data demonstrate that endo-1,3-β-D-glucanase modulates in vitro ruminal fermentation of diets varying in forage:concentrate by altering molar SCFA proportions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.